A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Clinical trial NCT06835972 · RECRUITING

Trial details

NCT number: NCT06835972
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Translocation Renal Cell Carcinoma

Start date: 2025-02-14
Primary completion: 2027-02-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.